Phenomenex Inc, Torrance, Calif, has introduced Strata-X-Drug B Plus, a solid phase extraction(SPE) sample preparation product for urine drug testing in clinical and forensic toxicology labs. The new product features Phenomenex’s solvent shielding technology, which enables enzyme hydrolysis to be carried out directly in the microplate well, reducing transfer steps, time requirements, and cost. The hydrolysis solution can be held for 6 hours or more, providing flexibility in protocol planning.

To meet the throughput demands of high-volume drug testing labs, Strata-X-Drug B Plus is available in a 96-well plate format. The product ensures high recovery, low variation, reduced solvent requirements, and time savings, and its protocol eliminates the conditioning and equilibration steps required for traditional SPE methods. The new sorbent enables the extraction of more than 22 drugs of abuse.

Jenny Cybulski, Phenomenex.

Jenny Cybulski, Phenomenex.

“Drug testing is on the rise, particularly in the face of the opioid crisis, and labs are under pressure to increase throughput and deliver results faster,” says Jenny Cybulski, product marketing manager for Phenomenex. “Urine is a widely used matrix for drug testing, yet it can be challenging to work with. New sample preparation approaches can make a big difference in achieving faster and more accurate results.”

For more information, visit Phenomenex.